Oculis Holding AG (OCS) Operating Expenses (2022 - 2026)
Quarterly Operating Expenses fell 24.32% to -$28.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$25.8 billion through Mar 2026, down 21.24% year-over-year, with the annual reading at -$103.7 million for FY2025, 22.93% down from the prior year.
Oculis Holding AG's Operating Expenses history spans 5 years, with the latest figure at -$28.0 million for Q1 2026.
- Operating Expenses came in at -$28.0 million for Q1 2026, down from -$26.3 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of -$7.3 million in Q3 2022 to a low of -$25.7 billion in Q3 2025.
- The 5-year median for Operating Expenses is -$21.1 million (2024), against an average of -$2.9 billion.
- The largest YoY upside for Operating Expenses was 63.43% in 2024 against a maximum downside of 141836.6% in 2024.
- Oculis Holding AG's Operating Expenses stood at -$11.8 million in 2022, then decreased by 18.6% to -$13.9 million in 2023, then tumbled by 41.32% to -$19.7 million in 2024, then tumbled by 33.61% to -$26.3 million in 2025, then fell by 6.4% to -$28.0 million in 2026.
- Per Business Quant, the three most recent readings for OCS's Operating Expenses are -$28.0 million (Q1 2026), -$26.3 million (Q4 2025), and -$25.7 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 2.97 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 4.33 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -138.30 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 15.76 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.85 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 2.96 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -3.82 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 898.54 Mn |
| 10 | Oculis Holding AG | 24.51 Bn | 24.21 Bn | - | -28.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.01 Mn |
| Dec 31, 2025 | -26.33 Mn |
| Sep 30, 2025 | -25.68 Bn |
| Jun 30, 2025 | -25.40 Mn |
| Mar 31, 2025 | -22.53 Mn |
| Dec 31, 2024 | -19.71 Mn |
| Sep 30, 2024 | -21.18 Bn |
| Jun 30, 2024 | -25.13 Mn |
| Mar 31, 2024 | -17.82 Mn |
| Dec 31, 2023 | -13.94 Mn |
| Sep 30, 2023 | -14.92 Mn |
| Jun 30, 2023 | -12.23 Mn |
| Mar 31, 2023 | -48.71 Mn |
| Dec 31, 2022 | -11.76 Mn |
| Sep 30, 2022 | -7.33 Mn |
| Jun 30, 2022 | -9.84 Mn |